🇺🇸 FDA
Patent

US 7825265

Compounds with activity at estrogen receptors

granted A61PA61P1/00A61P11/00

Quick answer

US patent 7825265 (Compounds with activity at estrogen receptors) held by ACADIA Pharmaceuticals Inc. expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADIA Pharmaceuticals Inc.
Grant date
Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P1/00, A61P11/00, A61P11/06, A61P15/02